Increasing incidence of target diseases such as hypertension, kidney failure from diabetes, across the globe coupled with rising geriatric population is expected to stimulate market growth
Market Size – USD 7.29 Billion in 2018, Market Growth - CAGR of 3.5%, Market Trends – Product launches and research for advanced hypertension care
NEW YORK, March 06, 2019 (GLOBE NEWSWIRE) -- The Angiotensin II receptor blockers market is projected to grow at a CAGR of 3.5%, in terms of value, from USD 7.29 Billion in 2018 to reach USD 9.61 Billion by 2026. This class of drug is used to block angiotensin II effects, and thus prevents the narrowing of blood vessels by angiotensin II action. The Angiotensin II receptor blockers facilitates widening of blood vessels and reduce blood pressure in an individual. In general, Angiotensin II receptor blockers are prescribed for patients with intolerance for angiotensin-converting-enzyme inhibitor.
The key factors contributing to the market growth includes increasing incidence of hypertension, chronic kidney diseases, kidney failure in diabetes, and heat failure, across the globe. For instance, according to American Heart Association statistics 2018, more than 103 million individuals in U.S. suffer from high blood pressure However, associated side effects (such as severe dizziness, insomnia, diarrhea, irregular heartbeat, and confusion) are the major hindrance for market growth during 2019-2026.
Request for a sample of this research report: https://www.reportsanddata.com/sample-enquiry-form/1156
Further key findings from the report suggest
- Angiotensin II Receptor Blockers market is rising at a growth rate of 4.4 percent in Asia Pacific followed by North America and Europe, with 3.4% and 3.2% CAGR respectively. Rising geriatric population in the region and rising obese population in the region will drive the demand for the market during forecast period across all regions.
- Increasing incidence of hypertension & cardiovascular diseases in younger population are likely to contribute to the overall market growth.
- Valsartan is the leading Angiotensin II Receptor Blocker in the market with market share of 20.8%. The Valsartan market was valued at USD 1.51 billion and is expected reach USD 1.97 billion by 2026. However, recalls of valsartan during 2018 and 2019, due to cancer concerns is a major challenge for the market growth of this market segment.
- Azilsartan is expected to be the fastest growing market segment during forecast period 2019-2026 with a CAGR of 4.5%.
- Asia Pacific is expected to witness a CAGR of 6.5 percent in the forecast period. Emerging markets such China and Japan are likely to witness high growth
- The lack of well-established medical reimbursements for hypertension in various developing regions is likely to hinder the market growth
- Key participants include AstraZeneca, Daichii Sankyo, Novartis, Abbvie, Lupin, Novartis, Abbvie, Takeda, AstraZeneca, and Zydus Cadila.
Read more at: https://www.reportsanddata.com/report-detail/angiotensin-ii-receptor-blockers-market
For the purpose of this report, Reports and Data has segmented the Angiotensin II receptor blockers market on the basis of type, application, and region:
Type (Revenue, USD Million; 2016–2026)
- Azilsartan
- Candesartan
- Eprosartan
- Irbesartan
- Losartan
- Olmesartan
- Telmisartan
- Valsartan
Application (Revenue, USD Million; 2016–2026)
- Hypertension
- Cardiovascular risks
- Kidney failure in diabetes
- Chronic kidney diseases
Regional Outlook (Revenue in USD Million; 2016–2026)
- North America
- U.S.
- Canada - Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of the Europe - Asia Pacific
- China
- India
- Japan
- Rest of Asia-Pacific - Middle East & Africa
- Latin America
- Brazil
Make an enquiry before buying this report at:
https://www.reportsanddata.com/make-enquiry-form/1156
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
News: www.reportsanddata.com/market-news